Prevention of Recurrent Mucinous Borderline Ovarian Tumor with Aromatase Inhibitor - 24/09/20
, Jodi A. Muscal, MD 2, Creighton L. Edwards, MD 3, Jennifer E. Dietrich, MD, MSc 4Abstract |
Background |
Aromatase inhibitors (AIs) are used for estrogen-modulated conditions. Some borderline ovarian tumors (BOT) express estrogen receptors. We present 2 cases of progression from mucinous cystadenoma to mucinous BOT (mBOT) after prior cystectomies in whom an AI was used with recurrence prevention.
Cases |
Two patients underwent laparoscopic ovarian cystectomy for mucinous cystadenoma. Serial imaging demonstrated recurrent ovarian cysts for which both underwent fertility sparing surgery (FSS) with ovarian cystectomy for mBOT. Both patients were initiated on an AI and have been without recurrence.
Summary and Conclusion |
BOT predominantly occur in reproductive aged females. FSS with cystectomy is an option, but recurrence occurs in 12-36% of cases. The use of AI in prevention of recurrent BOT shows promise, and more studies are needed to explore this treatment.
Le texte complet de cet article est disponible en PDF.Key Words : Aromatase inhibitor, Borderline ovarian tumor, Fertility sparing surgery
Plan
| The authors report no conflicts of interest. |
|
| The authors report no funding for this work. |
Vol 33 - N° 5
P. 610-612 - octobre 2020 Retour au numéro
Article précédent
- Uterovaginal Prolapse in a Newborn with Meningomyelocele: Case Report
- Alper Aykanat, Ebru Solako?lu, Burçak Bilginer, Hasan Tolga Çelik, ?ule Yi?it
- Successful Pregnancy after Intervention for Spindle-Cell Embryonal Rhabdomyosarcoma: A Case Report
- Sara M. Moufarrij, Creighton Edwards, Laurie McKenzie, Oluyemisi Adeyemi-Fowode
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?